CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Significant Increase in Short Interest

Posted by Carolyn Dwyer on Mar 14th, 2025

CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 500 shares, an increase of 400.0% from the February 13th total of 100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 5.0 days.

CellaVision AB (publ) Price Performance

OTCMKTS:CLVSF remained flat at $19.28 on Friday. The stock’s fifty day simple moving average is $19.46 and its 200-day simple moving average is $22.83. CellaVision AB has a 12-month low of $19.28 and a 12-month high of $19.91.

CellaVision AB (publ) Company Profile

(Get Free Report)

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.